Posted in | News | Green Energy | Wind Power

SheerWind to Commission 250 kW INVELOX Wind Power Generation Pilot Project for DUBAL

SheerWind, Inc., is pleased to announce a pilot project to be commissioned at Dubai Aluminium PJSC ("DUBAL"), which operates one of the world's largest aluminum smelting facilities and has a power generating capacity of nearly 2400 MW.

SheerWind's relationship with DUBAL will begin with a 250 kW INVELOX wind power generation pilot project. DUBAL's interest in SheerWind's technology is to reduce DUBAL's carbon footprint and its operations' impact on the environment.

SheerWind's INVELOX technology provides high-performance, cost-efficient wind energy:

  • Producing 600% more electrical energy (kWh)
  • Operating at wind speeds as low as 1 mile per hour
  • Reducing installation capital cost to less that $750 per KW
  • 90% Less land use than traditional wind power generation utilities
  • Increasing energy production capacity to record high of 72%
  • No harm to humans, animals, or flying creatures

"This installation is very exciting for SheerWind. We see this as the beginning of a great partnership with a company that is committed to reducing its carbon footprint and finding ways to make a difference globally," said Steve Hill, COO of SheerWind. "This partnership will assist in SheerWind's mission to provide affordable, clean, electrical energy to anyone—anywhere."

"We are very pleased to be the pioneer in this innovative pilot project in the GCC, especially as the project will contribute measurably to environmental conservation," said DUBAL'sTayeb Al Awadhi. "As a responsible corporate citizen, we are committed to sustainable principles. Moreover, the project is closely aligned with our corporate emphasis on continuous improvement through innovation."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.